Latest On Anavex Life Sciences Corp (AVXL):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-09 09:59 EST | News | Anavex Life Sciences GAAP EPS of -$0.17 beats by $0.01 | N/A |  |
| 2023-05-09 09:59 EST | News | Anavex Life Sciences Corp. (AVXL) Q2 2023 Earnings Call Transcript | N/A | |
| 2023-05-08 21:26 EST | News | Anavex Life Sciences Q2 2023 Earnings Preview | N/A | |
| 2023-05-04 09:38 EST | News | Anavex And The Antioxidant Treatment Of Alzheimer's Disease | N/A | |
| 2023-04-06 10:52 EST | News | Biogen And Eisai, Cassava Sciences, And Anavex: Clinical Trial Results In Need Of Revisions | N/A | |
| 2023-03-31 01:41 EST | News | Anavex gains on long-term data for Parkinson’s disease therapy | N/A | |
| 2023-03-16 14:51 EST | News | Buy Anavex For Its Likely Positive Alzheimer's Disease Data | N/A | |
| 2023-03-08 22:50 EST | News | Anavex: Many Questions Answered, A Few Still Left, But Things Are Progressing Well | N/A | |
| 2023-02-09 22:02 EST | News | Anavex Life Sciences: Recent Earnings Reveals Strong Cash Position To Get ANAVEX 2-73 Through FDA | N/A | |
| 2023-02-07 16:44 EST | News | Anavex Life Sciences GAAP EPS of -$0.17 beats by $0.02 | N/A | |
| 2023-02-07 16:44 EST | News | Anavex Life Sciences Corp. (AVXL) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-02-07 16:43 EST | News | Anavex hits two-month high after Q1 FY23 results | N/A | |
| 2023-02-06 15:12 EST | News | Anavex Life Sciences Q1 2023 Earnings Preview | N/A | |
| 2023-02-02 15:43 EST | News | Anavex gains as trial for Rett syndrome candidate exceeds enrollment target | N/A | |
| 2023-01-31 00:23 EST | News | Approval For Anavex's Blarcamesine Looks Inevitable After Biogen's Leqembi Approved | N/A | |
| 2023-01-17 17:52 EST | News | Anavex: Drug Treatments For Early Alzheimer's Disease | N/A | |
| 2023-01-12 19:56 EST | News | Anavex: Despite Positive Spin, No Clarity On Anomalies | N/A | |
| 2023-01-06 22:58 EST | News | Lilly, Anavex, other Alzheimer's drug developers rise modestly on Biogen lecanemab approval | N/A | |
| 2022-12-21 18:35 EST | News | How Well Does Anavex's New Alzheimer's Drug Compare Against Biogen's New Drug? | N/A | |
| 2022-12-10 07:25 EST | News | Anavex: A Thorough Approach To The Data | N/A | |
| 2022-12-08 04:30 EST | News | Anavex Life Sciences stock slides as downgraded to neutral at Cantor Fitzgerald | N/A | |
| 2022-12-06 15:57 EST | News | Anavex Life Sciences: The Little Company That Did | N/A | |
| 2022-12-04 07:23 EST | News | Anavex's Alzheimer's Results Leave Much To Be Desired | N/A | |
| 2022-12-02 19:33 EST | News | Anavex surges 40% as drug improves cognitive function in Alzheimer's patients, meets trial's goals | N/A | |
| 2022-12-02 19:32 EST | News | Jones sees Anavex as 'clear M&A target' after Alzheimer's drug's trial success | N/A | |
| 2022-11-30 14:05 EST | News | Anavex Life Sciences: Market Unimpressed As Major Alzheimer's Data Readout Arrives | N/A | |
| 2022-11-29 21:24 EST | News | Anavex defended at Cantor on prospects for rare disease therapy | N/A | |
| 2022-11-29 02:23 EST | News | Anavex Life Sciences Corp. (AVXL) Q4 2022 Earnings Call Transcript | N/A | |
| 2022-11-29 02:23 EST | News | Anavex drops 16% after fiscal 2022 update | N/A | |
| 2022-11-28 08:22 EST | News | Anavex Life Sciences GAAP EPS of -$0.18 misses by $0.01 | N/A | |
| 2022-11-08 08:37 EST | News | Anavex Life Sciences At A Pivotal Moment | N/A | |
| 2022-11-07 15:31 EST | News | Anavex therapy for Fragile X syndrome gets FDA orphan drug status | N/A | |
| 2022-09-29 23:01 EST | News | Biogen, Eisai cool off after massive run-up following lecanemab Alzheimer's data | N/A | |
| 2022-09-21 22:13 EST | News | Anavex wins new U.S. patent for lead candidate | N/A | |
| 2022-09-19 19:30 EST | News | Anavex Life Sciences: Upcoming Readouts In Alzheimer's And Parkinson's Disease Dementia | N/A | |
| 2022-09-08 07:56 EST | News | Anavex's Blarcamesine And Other Disease Modifying Treatments For Alzheimer's Disease | N/A | |
| 2022-08-11 23:27 EST | News | Anavex And The Debunking Of The Amyloid Hypothesis | N/A | |
| 2022-08-10 12:59 EST | News | Anavex Life Sciences Corp. (AVXL) CEO Dr. Christopher Missling on Q3 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-09 19:18 EST | News | Anavex Life Sciences GAAP EPS of -$0.16 beats by $0.01 | N/A | |
| 2022-08-08 20:39 EST | News | Anavex Life Sciences Q3 2022 Earnings Preview | N/A | |
| 2022-08-01 22:33 EST | News | Anavex gains on the effect of Alzheimer’s drug on genes | N/A | |
| 2022-06-24 04:00 EST | News | Anavex gains as Berenberg launches coverage with Buy rating | N/A | |
| 2022-06-02 22:17 EST | News | Anavex's Blarcamesine: Why It May Treat Alzheimer's Disease | N/A | |
| 2022-05-31 18:54 EST | News | Anavex: Increasing Shareholder Value Against All Odds | N/A | |
| 2022-05-11 00:41 EST | News | Anavex Life Sciences GAAP EPS of -$0.14 beats by $0.03 | N/A | |
| 2022-05-11 00:40 EST | News | Anavex Life Sciences GAAP EPS of -$0.14 beats by $0.05 | N/A | |
| 2022-05-11 00:40 EST | News | Anavex Life Sciences Corp. (AVXL) CEO Christopher Missling on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-10 02:36 EST | News | Anavex Life Sciences Q2 2022 Earnings Preview | N/A | |
| 2022-03-24 04:50 EST | News | Anavex's Blarcamesine And Cassava Sciences' Simufilam: The Stabilization Period For Alzheimer's Disease | N/A | |
| 2022-03-15 17:38 EST | News | Anavex posts mid-stage biomarker data for lead candidate | N/A | |
About Anavex Life Sciences Corp (AVXL):
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the treatment of frontotemporal dementia and other dementia indications; and preclinical clinical trials to treat Alzheimer's and Parkinson's diseases. Its preclinical drug candidates include ANAVEX 1-41, a sigma-1 receptor agonist for the treatment of depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company is based in New York, New York.
General
- Name Anavex Life Sciences Corp
- Symbol AVXL
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 20
- Last Split Factor1:4
- Last Split Date2015-10-07
- Fiscal Year EndSeptember
- IPO Date2006-08-02
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.anavex.com
View More
Valuation
- Price/Book (Most Recent Quarter) 23.64
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.50
- Next Year EPS Estimate -$0.55
- Next Quarter EPS Estimate -$0.11
- Return on Assets -41%
- Return on Equity -76%
- Earnings Per Share -$0.60
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 1.03 billion
- Analyst Target Price $15.2
- Book Value Per Share $0.69
View More
Share Statistics
- Shares Outstanding 69.49 million
- Shares Float 67.14 million
- % Held by Insiders 363%
- % Held by Institutions 19.19%
- Shares Short 3.96 million
- Shares Short Prior Month 4.01 million
- Short Ratio 0.47
- Short % of Float 6%
- Short % of Shares Outstanding 6%
View More
Technicals
- Beta 0.63
- 52 Week High $16.39
- 52 Week Low $2.23
- 50 Day Moving Average 12.26
- 200 Day Moving Average 6.92
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Anavex Life Sciences Corp (AVXL) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Anavex Life Sciences Corp (AVXL) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-11 | $N/A | -$0.12 | -$0.12 | 0% |
| 2020-09-30 | 2020-12-28 | $N/A | -$0.10 | -$0.13 | 23.08% |
| 2020-06-30 | 2020-08-06 | $N/A | -$0.11 | -$0.14 | 18.52% |
| 2020-03-31 | 2020-05-07 | $N/A | -$0.12 | -$0.16 | 23.42% |
| 2019-12-31 | 2020-02-06 | $N/A | -$0.12 | -$0.12 | 0% |
| 2019-09-30 | 2019-12-16 | $N/A | -$0.07 | -$0.15 | 52.4% |
| 2019-06-30 | 2019-08-07 | $N/A | -$0.14 | -$0.17 | 15.71% |
| 2019-03-31 | 2019-05-08 | $N/A | -$0.17 | -$0.14 | -21.43% |
| 2018-12-31 | 2019-02-07 | $N/A | -$0.16 | -$0.13 | -23.08% |
| 2018-09-30 | 2018-12-12 | $N/A | -$0.13 | -$0.11 | -18.18% |
| 2018-06-30 | 2018-08-09 | $N/A | -$0.06 | -$0.10 | 41.92% |
| 2018-03-31 | 2018-05-10 | $N/A | -$0.11 | -$0.10 | -10% |
| 2017-12-31 | 2018-02-07 | $N/A | -$0.09 | ||
| 2017-09-30 | 2017-12-11 | $N/A | -$0.12 | -$0.10 | -20% |
| 2017-06-30 | 2017-08-07 | $N/A | -$0.09 | -$0.09 | 1.33% |
| 2017-03-31 | 2017-05-10 | $N/A | -$0.04 | -$0.09 | 55.56% |
| 2016-12-31 | 2017-02-07 | $N/A | -$0.08 | -$0.11 | 27.27% |
| 2016-09-30 | 2016-12-12 | $N/A | -$0.18 | ||
| 2016-06-30 | 2016-08-11 | $N/A | -$0.06 | -$0.09 | 24.59% |
| 2016-03-31 | 2016-05-11 | $N/A | -$0.06 | -$0.16 | 60.81% |
| 2015-12-31 | 2016-02-08 | $N/A | -$0.12 | -$0.14 | 14.29% |
| 2015-09-30 | 2015-12-29 | $N/A | -$0.21 | -$0.06 | -250% |
| 2015-06-30 | 2015-08-17 | $N/A | -$0.22 | ||
| 2015-03-31 | 2015-05-15 | $N/A | -$0.12 | ||
| 2014-12-31 | 2015-02-18 | $N/A | -$0.06 | ||
| 2014-09-30 | 2014-12-29 | $N/A | -$0.20 | -$0.20 | 0% |
| 2014-06-30 | 2014-08-13 | $N/A | -$0.10 | ||
| 2014-03-31 | 2014-05-28 | $N/A | -$0.11 | ||
| 2013-12-31 | 2014-02-26 | $N/A | $0.03 | ||
| 2013-09-30 | 2013-09-30 | $N/A | -$0.40 | ||
| 2013-06-30 | 2013-06-30 | $N/A | -$0.02 | ||
| 2013-03-31 | 2013-03-31 | $N/A | -$0.01 | ||
| 2012-12-31 | 2012-12-31 | $N/A | -$0.06 | ||
| 2012-09-30 | 2012-09-30 | $N/A | -$0.10 | ||
| 2012-06-30 | 2012-06-30 | $N/A | -$0.64 | ||
| 2012-03-31 | 2012-03-31 | $N/A | -$0.13 | ||
| 2011-12-31 | 2011-12-31 | $N/A | -$0.33 | ||
| 2011-09-30 | 2011-09-30 | -$0.23 | |||
| 2011-06-30 | 2011-06-30 | $N/A | -$0.25 | ||
| 2011-03-31 | 2011-03-31 | -$0.31 | |||
| 2010-12-31 | 2010-12-31 | -$0.31 | |||
| 2010-09-30 | 2010-09-30 | -$0.52 | |||
| 2010-06-30 | 2010-06-30 | -$0.37 | |||
| 2010-03-31 | 2010-03-31 | -$0.33 | |||
| 2009-12-31 | 2009-12-31 | -$0.09 | |||
| 2009-09-30 | 2009-09-30 | -$0.36 | |||
| 2009-06-30 | 2009-06-30 | -$0.27 | |||
| 2009-03-31 | 2009-03-31 | -$0.25 | |||
| 2008-12-31 | 2008-12-31 | -$0.19 | |||
| 2008-09-30 | 2008-09-30 | -$0.42 | |||
| 2008-06-30 | 2008-06-30 | -$0.34 | |||
| 2008-03-31 | 2008-03-31 | -$0.14 | |||
| 2007-12-31 | 2007-12-31 | -$0.19 | |||
| 2007-09-30 | 2007-09-30 | -$0.24 | |||
| 2007-06-30 | 2007-06-30 | -$0.05 | |||
| 2007-03-31 | 2007-03-31 | -$0.04 | |||
| 2006-12-31 | 2006-12-31 | $-0.00 | |||
| 2006-09-30 | 2006-09-30 | $-0.00 |
Anavex Life Sciences Corp (AVXL) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Anavex Life Sciences Corp (AVXL) Chart:
Anavex Life Sciences Corp (AVXL) News:
Below you will find a list of latest news for Anavex Life Sciences Corp (AVXL) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Anavex Life Sciences Corp (AVXL) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-05-16 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-05-16 | 2 | 0 | CALL | 0 | 0 | 622.67 | TRUE | 0 | 0 |
| 2025-05-16 | 3 | 0 | CALL | 0 | 0 | 329.64 | TRUE | 0 | 0 |
| 2025-05-16 | 4 | 0 | CALL | 0 | 0 | 253.39 | TRUE | 0 | 0 |
| 2025-05-16 | 5 | 4 | CALL | 0 | 1 | 281.08 | TRUE | 0 | 0 |
| 2025-05-16 | 6 | 3.02 | CALL | 0 | 2 | 197.89 | TRUE | 0 | 0 |
| 2025-05-16 | 7 | 2.58 | CALL | 0 | 11 | 156.96 | TRUE | 0 | 0 |
| 2025-05-16 | 8 | 1.69 | CALL | 0 | 115 | 79.3 | TRUE | 0 | 0 |
| 2025-05-16 | 9 | 1.05 | CALL | 1 | 1244 | 87.83 | TRUE | 0 | 0 |
| 2025-05-16 | 10 | 0.55 | CALL | 41 | 2105 | 82.61 | FALSE | 0 | 0 |
| 2025-05-16 | 11 | 0.34 | CALL | 16 | 377 | 75.61 | FALSE | 0.04 | 0.13 |
| 2025-05-16 | 12 | 0.2 | CALL | 1 | 353 | 94.89 | FALSE | 0.02 | 0.11 |
| 2025-05-16 | 13 | 0.11 | CALL | 0 | 53 | 87.8 | FALSE | 0 | 0 |
| 2025-05-16 | 14 | 0.05 | CALL | 0 | 78 | 94.28 | FALSE | 0 | 0 |
| 2025-05-16 | 15 | 0.05 | CALL | 100 | 47 | 106.85 | FALSE | -0.03 | -0.38 |
| 2025-05-16 | 16 | 0.05 | CALL | 0 | 46 | 118.28 | FALSE | 0 | 0 |
| 2025-05-16 | 17 | 0.1 | CALL | 0 | 70 | 128.77 | FALSE | 0 | 0 |
| 2025-05-16 | 1 | 0 | PUT | 0 | 0 | 772.44 | FALSE | 0 | 0 |
| 2025-05-16 | 2 | 0 | PUT | 0 | 0 | 513.15 | FALSE | 0 | 0 |
| 2025-05-16 | 3 | 0 | PUT | 0 | 0 | 383.7 | FALSE | 0 | 0 |
| 2025-05-16 | 4 | 0 | PUT | 0 | 0 | 297.3 | FALSE | 0 | 0 |
| 2025-05-16 | 5 | 0.05 | PUT | 0 | 52 | 155.24 | FALSE | 0 | 0 |
| 2025-05-16 | 6 | 0.05 | PUT | 3 | 97 | 116.48 | FALSE | 0.05 | 0 |
| 2025-05-16 | 7 | 0.15 | PUT | 10 | 180 | 111.46 | FALSE | 0.15 | 0 |
| 2025-05-16 | 8 | 0.32 | PUT | 0 | 158 | 86.88 | FALSE | 0 | 0 |
| 2025-05-16 | 9 | 0.65 | PUT | 6 | 159 | 96.1 | FALSE | 0.1 | 0.18 |
| 2025-05-16 | 10 | 1.72 | PUT | 0 | 1062 | 68.65 | TRUE | 0 | 0 |
| 2025-05-16 | 11 | 2.13 | PUT | 0 | 30 | 85.53 | TRUE | 0 | 0 |
| 2025-05-16 | 12 | 0 | PUT | 0 | 0 | 90.55 | TRUE | 0 | 0 |
| 2025-05-16 | 13 | 0 | PUT | 0 | 0 | 118.62 | TRUE | 0 | 0 |
| 2025-05-16 | 14 | 0 | PUT | 0 | 0 | 152.78 | TRUE | 0 | 0 |
| 2025-05-16 | 15 | 0 | PUT | 0 | 0 | 151.55 | TRUE | 0 | 0 |
| 2025-05-16 | 16 | 0 | PUT | 0 | 0 | 192.03 | TRUE | 0 | 0 |
| 2025-05-16 | 17 | 0 | PUT | 0 | 0 | 228.77 | TRUE | 0 | 0 |
| 2025-06-20 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-06-20 | 2 | 0 | CALL | 0 | 0 | 244.59 | TRUE | 0 | 0 |
| 2025-06-20 | 3 | 0 | CALL | 0 | 0 | 373.38 | TRUE | 0 | 0 |
| 2025-06-20 | 4 | 0 | CALL | 0 | 0 | 305.12 | TRUE | 0 | 0 |
| 2025-06-20 | 5 | 0 | CALL | 0 | 0 | 128.53 | TRUE | 0 | 0 |
| 2025-06-20 | 6 | 0 | CALL | 0 | 0 | 120.35 | TRUE | 0 | 0 |
| 2025-06-20 | 7 | 0 | CALL | 0 | 0 | 105.96 | TRUE | 0 | 0 |
| 2025-06-20 | 8 | 0 | CALL | 0 | 0 | 88.27 | TRUE | 0 | 0 |
| 2025-06-20 | 9 | 1.4 | CALL | 0 | 24 | 83.35 | TRUE | 0 | 0 |
| 2025-06-20 | 10 | 0.9 | CALL | 0 | 180 | 78.94 | FALSE | 0 | 0 |
| 2025-06-20 | 11 | 0.75 | CALL | 0 | 30 | 60.23 | FALSE | 0 | 0 |
| 2025-06-20 | 12 | 0.5 | CALL | 5 | 63 | 84 | FALSE | -0.05 | -0.09 |
| 2025-06-20 | 13 | 0.4 | CALL | 0 | 18 | 70.34 | FALSE | 0 | 0 |
| 2025-06-20 | 14 | 0.25 | CALL | 10 | 87 | 86.41 | FALSE | 0.02 | 0.09 |
| 2025-06-20 | 15 | 0 | CALL | 0 | 0 | 106.48 | FALSE | 0 | 0 |
| 2025-06-20 | 16 | 0 | CALL | 0 | 0 | 129.81 | FALSE | 0 | 0 |
| 2025-06-20 | 17 | 0 | CALL | 0 | 0 | 142.96 | FALSE | 0 | 0 |
| 2025-06-20 | 1 | 0 | PUT | 0 | 0 | 577.21 | FALSE | 0 | 0 |
| 2025-06-20 | 2 | 0 | PUT | 0 | 0 | 364.4 | FALSE | 0 | 0 |
| 2025-06-20 | 3 | 0 | PUT | 0 | 0 | 271.76 | FALSE | 0 | 0 |
| 2025-06-20 | 4 | 0 | PUT | 0 | 0 | 243.12 | FALSE | 0 | 0 |
| 2025-06-20 | 5 | 0.02 | PUT | 0 | 8 | 165.8 | FALSE | 0 | 0 |
| 2025-06-20 | 6 | 0.56 | PUT | 0 | 1 | 135.5 | FALSE | 0 | 0 |
| 2025-06-20 | 7 | 0.3 | PUT | 0 | 10 | 125.65 | FALSE | 0 | 0 |
| 2025-06-20 | 8 | 0 | PUT | 0 | 0 | 82.07 | FALSE | 0 | 0 |
| 2025-06-20 | 9 | 1.06 | PUT | 0 | 1 | 105.12 | FALSE | 0 | 0 |
| 2025-06-20 | 10 | 1.85 | PUT | 0 | 1 | 99.83 | TRUE | 0 | 0 |
| 2025-06-20 | 11 | 0 | PUT | 0 | 0 | 89.83 | TRUE | 0 | 0 |
| 2025-06-20 | 12 | 0 | PUT | 0 | 0 | 98.39 | TRUE | 0 | 0 |
| 2025-06-20 | 13 | 0 | PUT | 0 | 0 | 99.29 | TRUE | 0 | 0 |
| 2025-06-20 | 14 | 0 | PUT | 0 | 0 | 98.23 | TRUE | 0 | 0 |
| 2025-06-20 | 15 | 0 | PUT | 0 | 0 | 122.54 | TRUE | 0 | 0 |
| 2025-06-20 | 16 | 0 | PUT | 0 | 0 | 118.2 | TRUE | 0 | 0 |
| 2025-06-20 | 17 | 0 | PUT | 0 | 0 | 158.7 | TRUE | 0 | 0 |
| 2025-07-18 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-07-18 | 2 | 0 | CALL | 0 | 0 | 420.46 | TRUE | 0 | 0 |
| 2025-07-18 | 3 | 0 | CALL | 0 | 0 | 322.35 | TRUE | 0 | 0 |
| 2025-07-18 | 4 | 0 | CALL | 0 | 0 | 107.48 | TRUE | 0 | 0 |
| 2025-07-18 | 5 | 4 | CALL | 0 | 18 | 92.74 | TRUE | 0 | 0 |
| 2025-07-18 | 6 | 3.2 | CALL | 0 | 68 | 118.26 | TRUE | 0 | 0 |
| 2025-07-18 | 7 | 2.5 | CALL | 0 | 42 | 80.96 | TRUE | 0 | 0 |
| 2025-07-18 | 8 | 2.25 | CALL | 4 | 287 | 81.42 | TRUE | -0.27 | -0.11 |
| 2025-07-18 | 9 | 1.9 | CALL | 0 | 533 | 86.35 | TRUE | 0 | 0 |
| 2025-07-18 | 10 | 1.35 | CALL | 120 | 3271 | 84.6 | FALSE | -0.15 | -0.1 |
| 2025-07-18 | 11 | 0.92 | CALL | 0 | 492 | 82 | FALSE | 0 | 0 |
| 2025-07-18 | 12 | 0.76 | CALL | 11 | 407 | 84.06 | FALSE | 0.76 | 0 |
| 2025-07-18 | 13 | 0.6 | CALL | 0 | 115 | 72.77 | FALSE | 0 | 0 |
| 2025-07-18 | 14 | 0.55 | CALL | 0 | 434 | 87.66 | FALSE | 0 | 0 |
| 2025-07-18 | 15 | 0.45 | CALL | 0 | 656 | 86.81 | FALSE | 0 | 0 |
| 2025-07-18 | 16 | 0.36 | CALL | 0 | 503 | 98.32 | FALSE | 0 | 0 |
| 2025-07-18 | 17 | 0.3 | CALL | 0 | 1058 | 101.06 | FALSE | 0 | 0 |
| 2025-07-18 | 18 | 0.21 | CALL | 0 | 57 | 113.61 | FALSE | 0 | 0 |
| 2025-07-18 | 20 | 0.13 | CALL | 0 | 330 | 133.04 | FALSE | 0 | 0 |
| 2025-07-18 | 25 | 0.1 | CALL | 0 | 132 | 140.56 | FALSE | 0 | 0 |
| 2025-07-18 | 1 | 0.1 | PUT | 0 | 25 | 285.19 | FALSE | 0 | 0 |
| 2025-07-18 | 2 | 0 | PUT | 0 | 0 | 312.79 | FALSE | 0 | 0 |
| 2025-07-18 | 3 | 0.5 | PUT | 0 | 276 | 184.23 | FALSE | 0 | 0 |
| 2025-07-18 | 4 | 0.1 | PUT | 0 | 244 | 142.75 | FALSE | 0 | 0 |
| 2025-07-18 | 5 | 0.2 | PUT | 0 | 238 | 107.1 | FALSE | 0 | 0 |
| 2025-07-18 | 6 | 0.45 | PUT | 0 | 360 | 103.46 | FALSE | 0 | 0 |
| 2025-07-18 | 7 | 0.75 | PUT | 0 | 407 | 80.36 | FALSE | 0 | 0 |
| 2025-07-18 | 8 | 0.88 | PUT | 3 | 403 | 91.9 | FALSE | -0.07 | -0.07 |
| 2025-07-18 | 9 | 1.35 | PUT | 7 | 325 | 91.24 | FALSE | 0.01 | 0.01 |
| 2025-07-18 | 10 | 3.05 | PUT | 0 | 2515 | 90.97 | TRUE | 0 | 0 |
| 2025-07-18 | 11 | 4 | PUT | 0 | 17 | 87.31 | TRUE | 0 | 0 |
| 2025-07-18 | 12 | 3.5 | PUT | 0 | 164 | 89.31 | TRUE | 0 | 0 |
| 2025-07-18 | 13 | 5.69 | PUT | 0 | 5 | 98.67 | TRUE | 0 | 0 |
| 2025-07-18 | 14 | 6.06 | PUT | 0 | 0 | 115.52 | TRUE | 0 | 0 |
| 2025-07-18 | 15 | 0 | PUT | 0 | 0 | 102.38 | TRUE | 0 | 0 |
| 2025-07-18 | 16 | 7.4 | PUT | 0 | 11 | 85.43 | TRUE | 0 | 0 |
| 2025-07-18 | 17 | 0 | PUT | 0 | 0 | 114.43 | TRUE | 0 | 0 |
| 2025-07-18 | 18 | 0 | PUT | 0 | 0 | 108.75 | TRUE | 0 | 0 |
| 2025-07-18 | 20 | 0 | PUT | 0 | 0 | 148.73 | TRUE | 0 | 0 |
| 2025-07-18 | 25 | 15.6 | PUT | 0 | 2 | 166.93 | TRUE | 0 | 0 |
| 2025-10-17 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 2 | 0 | CALL | 0 | 0 | 253.39 | TRUE | 0 | 0 |
| 2025-10-17 | 3 | 0 | CALL | 0 | 0 | 135.7 | TRUE | 0 | 0 |
| 2025-10-17 | 4 | 5.7 | CALL | 0 | 6 | 77.34 | TRUE | 0 | 0 |
| 2025-10-17 | 5 | 4.4 | CALL | 0 | 1 | 88.64 | TRUE | 0 | 0 |
| 2025-10-17 | 6 | 4.1 | CALL | 5 | 0 | 86.06 | TRUE | 4.1 | 0 |
| 2025-10-17 | 7 | 3.9 | CALL | 0 | 3 | 79.42 | TRUE | 0 | 0 |
| 2025-10-17 | 8 | 3.05 | CALL | 0 | 14 | 85.67 | TRUE | 0 | 0 |
| 2025-10-17 | 9 | 2.2 | CALL | 0 | 18 | 96.43 | TRUE | 0 | 0 |
| 2025-10-17 | 10 | 2.45 | CALL | 0 | 97 | 84.4 | FALSE | 0 | 0 |
| 2025-10-17 | 11 | 1.82 | CALL | 0 | 120 | 94.94 | FALSE | 0 | 0 |
| 2025-10-17 | 12 | 1.73 | CALL | 10 | 1040 | 94.95 | FALSE | -0.02 | -0.01 |
| 2025-10-17 | 13 | 1.38 | CALL | 1 | 8 | 90.34 | FALSE | 1.38 | 0 |
| 2025-10-17 | 14 | 1.2 | CALL | 0 | 6 | 94.84 | FALSE | 0 | 0 |
| 2025-10-17 | 15 | 1.15 | CALL | 0 | 272 | 104.54 | FALSE | 0 | 0 |
| 2025-10-17 | 16 | 1 | CALL | 0 | 15 | 102.59 | FALSE | 0 | 0 |
| 2025-10-17 | 17 | 1 | CALL | 0 | 2 | 88.6 | FALSE | 0 | 0 |
| 2025-10-17 | 1 | 0 | PUT | 0 | 0 | 359.46 | FALSE | 0 | 0 |
| 2025-10-17 | 2 | 0.1 | PUT | 0 | 4 | 228.23 | FALSE | 0 | 0 |
| 2025-10-17 | 3 | 0.24 | PUT | 0 | 67 | 173.17 | FALSE | 0 | 0 |
| 2025-10-17 | 4 | 0.4 | PUT | 1 | 143 | 124.42 | FALSE | 0.07 | 0.21 |
| 2025-10-17 | 5 | 0.4 | PUT | 0 | 15 | 110.85 | FALSE | 0 | 0 |
| 2025-10-17 | 6 | 0.94 | PUT | 1 | 277 | 112.77 | FALSE | 0.07 | 0.08 |
| 2025-10-17 | 7 | 1.46 | PUT | 0 | 6 | 101.56 | FALSE | 0 | 0 |
| 2025-10-17 | 8 | 1.75 | PUT | 0 | 94 | 98.49 | FALSE | 0 | 0 |
| 2025-10-17 | 9 | 2.25 | PUT | 0 | 23 | 104.6 | FALSE | 0 | 0 |
| 2025-10-17 | 10 | 3.37 | PUT | 0 | 2 | 104.55 | TRUE | 0 | 0 |
| 2025-10-17 | 11 | 3.5 | PUT | 0 | 11 | 91.91 | TRUE | 0 | 0 |
| 2025-10-17 | 12 | 4.4 | PUT | 0 | 977 | 94.11 | TRUE | 0 | 0 |
| 2025-10-17 | 13 | 0 | PUT | 0 | 0 | 99.56 | TRUE | 0 | 0 |
| 2025-10-17 | 14 | 0 | PUT | 0 | 0 | 107.71 | TRUE | 0 | 0 |
| 2025-10-17 | 15 | 0 | PUT | 0 | 0 | 109.11 | TRUE | 0 | 0 |
| 2025-10-17 | 16 | 0 | PUT | 0 | 0 | 101.42 | TRUE | 0 | 0 |
| 2025-10-17 | 17 | 0 | PUT | 0 | 0 | 117.63 | TRUE | 0 | 0 |
| 2026-01-16 | 3 | 6.82 | CALL | 0 | 1434 | 137.5 | TRUE | 0 | 0 |
| 2026-01-16 | 5 | 5.04 | CALL | 36 | 628 | 83.53 | TRUE | -0.16 | -0.03 |
| 2026-01-16 | 6 | 0 | CALL | 0 | 0 | 84.13 | TRUE | 0 | 0 |
| 2026-01-16 | 7 | 3.99 | CALL | 80 | 1284 | 90.76 | TRUE | 3.99 | 0 |
| 2026-01-16 | 8 | 0 | CALL | 0 | 0 | 91.74 | TRUE | 0 | 0 |
| 2026-01-16 | 9 | 3.2 | CALL | 0 | 4 | 82.23 | TRUE | 0 | 0 |
| 2026-01-16 | 10 | 2.65 | CALL | 81 | 4512 | 86.81 | FALSE | -0.09 | -0.03 |
| 2026-01-16 | 11 | 2.5 | CALL | 0 | 1 | 86.31 | FALSE | 0 | 0 |
| 2026-01-16 | 12 | 2.2 | CALL | 5 | 3226 | 90.78 | FALSE | 2.2 | 0 |
| 2026-01-16 | 15 | 1.63 | CALL | 16 | 6390 | 92.17 | FALSE | -0.02 | -0.01 |
| 2026-01-16 | 17 | 1.46 | CALL | 5 | 62 | 96.3 | FALSE | 1.46 | 0 |
| 2026-01-16 | 20 | 1.1 | CALL | 5 | 6070 | 95.68 | FALSE | 0.02 | 0.02 |
| 2026-01-16 | 25 | 0.75 | CALL | 0 | 2109 | 97.66 | FALSE | 0 | 0 |
| 2026-01-16 | 3 | 0.23 | PUT | 2 | 1012 | 109.72 | FALSE | -0.07 | -0.23 |
| 2026-01-16 | 5 | 0.8 | PUT | 15 | 2224 | 107 | FALSE | 0 | 0 |
| 2026-01-16 | 6 | 1.2 | PUT | 0 | 55 | 104.54 | FALSE | 0 | 0 |
| 2026-01-16 | 7 | 1.7 | PUT | 10 | 572 | 106.16 | FALSE | -0.05 | -0.03 |
| 2026-01-16 | 8 | 0 | PUT | 0 | 0 | 103.09 | FALSE | 0 | 0 |
| 2026-01-16 | 9 | 0 | PUT | 0 | 0 | 103.94 | FALSE | 0 | 0 |
| 2026-01-16 | 10 | 3.47 | PUT | 10 | 2126 | 104.62 | TRUE | 3.47 | 0 |
| 2026-01-16 | 11 | 0 | PUT | 0 | 0 | 101.03 | TRUE | 0 | 0 |
| 2026-01-16 | 12 | 5.15 | PUT | 0 | 235 | 100.32 | TRUE | 0 | 0 |
| 2026-01-16 | 15 | 7.3 | PUT | 1 | 120 | 106.96 | TRUE | 0.1 | 0.01 |
| 2026-01-16 | 17 | 0 | PUT | 0 | 0 | 108.12 | TRUE | 0 | 0 |
| 2026-01-16 | 20 | 13.07 | PUT | 0 | 68 | 114.7 | TRUE | 0 | 0 |
| 2026-01-16 | 25 | 0 | PUT | 0 | 0 | 112.16 | TRUE | 0 | 0 |
| 2027-01-15 | 3 | 6.9 | CALL | 0 | 119 | 109.19 | TRUE | 0 | 0 |
| 2027-01-15 | 5 | 5.09 | CALL | 0 | 81 | 104.45 | TRUE | 0 | 0 |
| 2027-01-15 | 7 | 4.6 | CALL | 0 | 200 | 74.45 | TRUE | 0 | 0 |
| 2027-01-15 | 10 | 3.95 | CALL | 0 | 886 | 80.59 | FALSE | 0 | 0 |
| 2027-01-15 | 12 | 3.37 | CALL | 0 | 91 | 90.66 | FALSE | 0 | 0 |
| 2027-01-15 | 15 | 2.88 | CALL | 0 | 99 | 79.13 | FALSE | 0 | 0 |
| 2027-01-15 | 17 | 2.76 | CALL | 0 | 21 | 82.97 | FALSE | 0 | 0 |
| 2027-01-15 | 20 | 2.39 | CALL | 3 | 995 | 87.46 | FALSE | -0.01 | -0 |
| 2027-01-15 | 3 | 0.85 | PUT | 0 | 2 | 135.35 | FALSE | 0 | 0 |
| 2027-01-15 | 5 | 1.8 | PUT | 0 | 3 | 129.93 | FALSE | 0 | 0 |
| 2027-01-15 | 7 | 2.8 | PUT | 0 | 2 | 82.41 | FALSE | 0 | 0 |
| 2027-01-15 | 10 | 4.4 | PUT | 0 | 82 | 88.5 | TRUE | 0 | 0 |
| 2027-01-15 | 12 | 0 | PUT | 0 | 0 | 90.48 | TRUE | 0 | 0 |
| 2027-01-15 | 15 | 0 | PUT | 0 | 0 | 93.12 | TRUE | 0 | 0 |
| 2027-01-15 | 17 | 10.7 | PUT | 0 | 2 | 92.5 | TRUE | 0 | 0 |
| 2027-01-15 | 20 | 13.4 | PUT | 0 | 2 | 93.72 | TRUE | 0 | 0 |
Latest AVXL Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 200 | $7.57 |
| Jun 13, 2022 7:59 PM EST | 58 | $7.56 |
| Jun 13, 2022 7:59 PM EST | 1 | $7.57 |
| Jun 13, 2022 7:59 PM EST | 100 | $7.57 |
| Jun 13, 2022 7:59 PM EST | 29 | $7.56 |
Anavex Life Sciences Corp (AVXL) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000712/0001731122-20-000712-index.htm |
| 2017-06-09 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1314052/000000000017020197/0000000000-17-020197-index.htm |
| 2019-07-11 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1314052/000000000019011025/0000000000-19-011025-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1314052/000083423720008231/0000834237-20-008231-index.htm |
| 2020-03-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1314052/000083423720009195/0000834237-20-009195-index.htm |
| 2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1314052/000090571818000242/0000905718-18-000242-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1314052/000090571819000231/0000905718-19-000231-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1314052/000090571820000234/0000905718-20-000234-index.htm |
| 2019-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000121390019010249/0001213900-19-010249-index.htm |
| 2019-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1314052/000121390019010601/0001213900-19-010601-index.htm |
| 2019-06-12 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1314052/000121390019010604/0001213900-19-010604-index.htm |
| 2019-07-03 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1314052/000121390019012072/0001213900-19-012072-index.htm |
| 2019-07-12 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1314052/000121390019012578/0001213900-19-012578-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1314052/000121390019014791/0001213900-19-014791-index.htm |
| 2019-09-13 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1314052/000121390019018007/0001213900-19-018007-index.htm |
| 2019-09-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1314052/000121390019018012/0001213900-19-018012-index.htm |
| 2019-09-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1314052/000121390019018023/0001213900-19-018023-index.htm |
| 2019-09-16 | AW | Amendment Withdrawal Request | https://www.sec.gov/Archives/edgar/data/1314052/000121390019018132/0001213900-19-018132-index.htm |
| 2019-09-17 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1314052/000121390019018310/0001213900-19-018310-index.htm |
| 2017-06-09 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1314052/000161577417003075/0001615774-17-003075-index.htm |
| 2017-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004118/0001615774-17-004118-index.htm |
| 2017-08-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004281/0001615774-17-004281-index.htm |
| 2017-08-11 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004290/0001615774-17-004290-index.htm |
| 2017-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004399/0001615774-17-004399-index.htm |
| 2017-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004574/0001615774-17-004574-index.htm |
| 2017-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004587/0001615774-17-004587-index.htm |
| 2017-08-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004745/0001615774-17-004745-index.htm |
| 2017-08-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004809/0001615774-17-004809-index.htm |
| 2017-08-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004886/0001615774-17-004886-index.htm |
| 2017-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004918/0001615774-17-004918-index.htm |
| 2017-09-07 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004964/0001615774-17-004964-index.htm |
| 2017-09-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004994/0001615774-17-004994-index.htm |
| 2017-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005014/0001615774-17-005014-index.htm |
| 2017-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005088/0001615774-17-005088-index.htm |
| 2017-09-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005183/0001615774-17-005183-index.htm |
| 2017-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005226/0001615774-17-005226-index.htm |
| 2017-09-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005351/0001615774-17-005351-index.htm |
| 2017-09-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005440/0001615774-17-005440-index.htm |
| 2017-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005508/0001615774-17-005508-index.htm |
| 2017-10-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005604/0001615774-17-005604-index.htm |
| 2017-10-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005634/0001615774-17-005634-index.htm |
| 2017-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005731/0001615774-17-005731-index.htm |
| 2017-10-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005767/0001615774-17-005767-index.htm |
| 2017-10-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005807/0001615774-17-005807-index.htm |
| 2017-10-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005861/0001615774-17-005861-index.htm |
| 2017-10-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005929/0001615774-17-005929-index.htm |
| 2017-12-11 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1314052/000161577417007272/0001615774-17-007272-index.htm |
| 2017-12-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417007355/0001615774-17-007355-index.htm |
| 2017-12-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577417007357/0001615774-17-007357-index.htm |
| 2018-02-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1314052/000161577418000934/0001615774-18-000934-index.htm |
| 2018-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577418001587/0001615774-18-001587-index.htm |
| 2018-03-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577418001629/0001615774-18-001629-index.htm |
| 2018-03-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577418001650/0001615774-18-001650-index.htm |
| 2018-03-08 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1314052/000161577418001673/0001615774-18-001673-index.htm |
| 2018-03-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1314052/000161577418001701/0001615774-18-001701-index.htm |
| 2018-03-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577418001744/0001615774-18-001744-index.htm |
| 2018-04-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1314052/000161577418002786/0001615774-18-002786-index.htm |
| 2018-04-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577418002846/0001615774-18-002846-index.htm |
| 2018-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1314052/000161577418003574/0001615774-18-003574-index.htm |
| 2018-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577418004019/0001615774-18-004019-index.htm |
| 2018-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577418004023/0001615774-18-004023-index.htm |
| 2018-07-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1314052/000161577418006278/0001615774-18-006278-index.htm |
| 2018-07-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1314052/000161577418006280/0001615774-18-006280-index.htm |
| 2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1314052/000161577418007805/0001615774-18-007805-index.htm |
| 2018-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577418010436/0001615774-18-010436-index.htm |
| 2018-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577418010439/0001615774-18-010439-index.htm |
| 2018-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577418010441/0001615774-18-010441-index.htm |
| 2018-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577418010443/0001615774-18-010443-index.htm |
| 2018-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577418010445/0001615774-18-010445-index.htm |
| 2018-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577418010447/0001615774-18-010447-index.htm |
| 2018-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577418010620/0001615774-18-010620-index.htm |
| 2018-12-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1314052/000161577418014328/0001615774-18-014328-index.htm |
| 2019-01-25 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1314052/000161577419001031/0001615774-19-001031-index.htm |
| 2019-01-31 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1314052/000161577419001498/0001615774-19-001498-index.htm |
| 2019-02-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1314052/000161577419002057/0001615774-19-002057-index.htm |
| 2019-02-11 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1314052/000161577419002242/0001615774-19-002242-index.htm |
| 2019-03-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1314052/000161577419004136/0001615774-19-004136-index.htm |
| 2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1314052/000161577419004139/0001615774-19-004139-index.htm |
| 2019-04-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1314052/000161577419005452/0001615774-19-005452-index.htm |
| 2019-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000161577419007213/0001615774-19-007213-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1314052/000161577419007324/0001615774-19-007324-index.htm |
| 2019-12-16 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1314052/000173112219000784/0001731122-19-000784-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000018/0001731122-20-000018-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000019/0001731122-20-000019-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000020/0001731122-20-000020-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000021/0001731122-20-000021-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000022/0001731122-20-000022-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000023/0001731122-20-000023-index.htm |
| 2020-01-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000024/0001731122-20-000024-index.htm |
| 2020-02-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000103/0001731122-20-000103-index.htm |
| 2020-02-20 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000195/0001731122-20-000195-index.htm |
| 2020-03-23 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000289/0001731122-20-000289-index.htm |
| 2020-04-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000360/0001731122-20-000360-index.htm |
| 2020-05-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000430/0001731122-20-000430-index.htm |
| 2020-05-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000431/0001731122-20-000431-index.htm |
| 2020-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000432/0001731122-20-000432-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000447/0001731122-20-000447-index.htm |
| 2020-07-02 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000711/0001731122-20-000711-index.htm |
| 2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000712/0001731122-20-000712-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1314052/000173112220000807/0001731122-20-000807-index.htm |
| 2020-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1314052/000173112220001047/0001731122-20-001047-index.htm |
| 2020-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1314052/000173112220001114/0001731122-20-001114-index.htm |
| 2017-06-12 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1314052/999999999517001508/9999999995-17-001508-index.htm |
| 2019-07-15 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1314052/999999999519001606/9999999995-19-001606-index.htm |
| 2019-09-20 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1314052/999999999519002138/9999999995-19-002138-index.htm |
Anavex Life Sciences Corp (AVXL) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Anavex Life Sciences Corp (AVXL). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 363%Institutional Ownership: 1919%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2017-08-11 | CHRISTOPHER U MISSLING | President and CEO | Buy | 750.00 | 3.55 | 2,662.50 | 1,004,000.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004281/0001615774-17-004281-index.htm |
| 2017-08-14 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 3.70 | 1,387.50 | 1,004,375.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004399/0001615774-17-004399-index.htm |
| 2017-08-18 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 3.81 | 1,428.75 | 1,004,750.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004574/0001615774-17-004574-index.htm |
| 2017-08-21 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.07 | 1,526.25 | 1,005,125.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004587/0001615774-17-004587-index.htm |
| 2017-08-24 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.54 | 1,702.50 | 1,005,500.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004745/0001615774-17-004745-index.htm |
| 2017-08-28 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.44 | 1,665.00 | 1,005,875.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004809/0001615774-17-004809-index.htm |
| 2017-08-31 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.48 | 1,680.00 | 1,006,250.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004886/0001615774-17-004886-index.htm |
| 2017-09-05 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.90 | 1,837.50 | 1,006,625.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004918/0001615774-17-004918-index.htm |
| 2017-09-07 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.76 | 1,785.00 | 1,007,000.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417004994/0001615774-17-004994-index.htm |
| 2017-09-11 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.81 | 1,803.75 | 1,007,375.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005014/0001615774-17-005014-index.htm |
| 2017-09-14 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.58 | 1,717.50 | 1,007,750.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005088/0001615774-17-005088-index.htm |
| 2017-09-18 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.40 | 1,650.00 | 1,008,125.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005183/0001615774-17-005183-index.htm |
| 2017-09-20 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.23 | 1,586.25 | 1,008,500.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005226/0001615774-17-005226-index.htm |
| 2017-09-26 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 3.88 | 1,455.00 | 1,008,875.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005351/0001615774-17-005351-index.htm |
| 2017-09-28 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.21 | 1,578.75 | 1,009,250.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005440/0001615774-17-005440-index.htm |
| 2017-10-02 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.20 | 1,575.00 | 1,009,625.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005508/0001615774-17-005508-index.htm |
| 2017-10-05 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.30 | 1,612.50 | 1,010,000.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005604/0001615774-17-005604-index.htm |
| 2017-10-13 | CHRISTOPHER U MISSLING | President and CEO | Buy | 750.00 | 4.22 | 3,165.00 | 1,010,750.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005731/0001615774-17-005731-index.htm |
| 2017-10-17 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.27 | 1,601.25 | 1,011,125.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005767/0001615774-17-005767-index.htm |
| 2017-10-19 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.49 | 1,683.75 | 1,011,500.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005807/0001615774-17-005807-index.htm |
| 2017-10-24 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.92 | 1,845.00 | 1,011,875.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005861/0001615774-17-005861-index.htm |
| 2017-10-25 | CHRISTOPHER U MISSLING | President and CEO | Buy | 375.00 | 4.39 | 1,646.25 | 1,012,250.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577417005929/0001615774-17-005929-index.htm |
| 2018-03-02 | CHRISTOPHER U MISSLING | Director, President & CEO | Buy | 1,650.00 | 2.41 | 3,976.50 | 1,013,900.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577418001587/0001615774-18-001587-index.htm |
| 2018-03-05 | CHRISTOPHER U MISSLING | President and CEO | Buy | 1,500.00 | 2.63 | 3,945.00 | 1,015,400.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577418001629/0001615774-18-001629-index.htm |
| 2018-03-06 | CHRISTOPHER U MISSLING | President and CEO | Buy | 1,450.00 | 2.73 | 3,958.50 | 1,016,850.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577418001650/0001615774-18-001650-index.htm |
| 2018-03-07 | CHRISTOPHER U MISSLING | President and CEO | Buy | 1,360.00 | 2.92 | 3,971.20 | 1,018,210.00 | https://www.sec.gov/Archives/edgar/data/1314052/000161577418001744/0001615774-18-001744-index.htm |